Paxneury

guanfacine hydrochloride · Neuraxpharm Pharmaceuticals S.L.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Paxneury, covering 2025-03-11 to 2026-07-15. Get the full timeline:

Most recent: EMA Authorised: Paxneury (guanfacine hydrochloride) — Neuraxpharm Pharmaceuticals S.L.